Immobilization of ZnO-TiO2 Nanocomposite into Polyimidazolium Amphiphilic Chitosan Film, Targeting Improving Its Antimicrobial and Antibiofilm Applications

Author:

Abd El-Fattah Wesam12,Alfaifi Mohammad Y.3ORCID,Alkabli Jafar4,Ramadan Heba A.5,Shati Ali A.3,Elbehairi Serag Eldin I.3ORCID,Elshaarawy Reda F. M.67ORCID,Kamal Islam8ORCID,Saleh Moustafa M.9

Affiliation:

1. Chemistry Department, College of Science, IMSIU (Imam Mohammad Ibn Saud Islamic University), P.O. Box 5701, Riyadh 11432, Saudi Arabia

2. Department of Chemistry, Faculty of Science, Port Said University, Port Said 42521, Egypt

3. Biology Department, Faculty of Science, King Khalid University, Abha 61413, Saudi Arabia

4. Department of Chemistry, College of Sciences and Arts—Alkamil, University of Jeddah, Jeddah 23218, Saudi Arabia

5. Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Mansoura 11152, Egypt

6. Department of Chemistry, Faculty of Science, Suez University, Suez 43533, Egypt

7. Institute for Inorganic Chemistry and Structural Chemistry, Düsseldorf University, 40225 Düsseldorf, Germany

8. Department of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt

9. Microbiology and Immunology Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt

Abstract

This study presents a green protocol for the fabrication of a multifunctional smart nanobiocomposite (NBC) (ZnO-PIACSB-TiO2) for secure antimicrobial and antibiofilm applications. First, shrimp shells were upgraded to a polyimidazolium amphiphilic chitosan Schiff base (PIACSB) through a series of physicochemical processes. After that, the PIACSB was used as an encapsulating and coating agent to manufacture a hybrid NBC in situ by co-encapsulating ZnONPs and TiO2NPs. The physicochemical and visual characteristics of the new NBC were investigated by spectral, microscopic, electrical, and thermal methods. The antimicrobial indices revealed that the newly synthesized, PIACSB-coated TiO2–ZnO nanocomposite is an exciting antibiotic due to its amazing antimicrobial activity (MIC/MBC→0.34/0.68 μg/mL, 0.20/0.40 μg/mL, and 0.15/0.30 μg/mL working against S. aureus, E. coli, and P. aeruginosa, respectively) and antifungal capabilities. Additionally, ZnO-PIACSB-TiO2 is a potential fighter of bacterial biofilms, with the results being superior to those of the positive control (Cipro), which worked against S. aureus (only 8.7% ± 1.9 biofilm growth), E. coli (only 1.4% ± 1.1 biofilm growth), and P. aeruginosa (only 0.85% ± 1.3 biofilm growth). Meanwhile, the NBC exhibits excellent biocompatibility, as evidenced by its IC50 values against both L929 and HSF (135 and 143 µg/mL), which are significantly higher than those of the MIC doses (0.24–24.85 µg/mL) that work against all tested microbes, as well as the uncoated nanocomposite (IC50 = 19.36 ± 2.04 and 23.48 ± 1.56 µg/mL). These findings imply that the new PIACSB-coated nanocomposite film may offer promising multifunctional food packaging additives to address the customer demand for safe, eco-friendly food products with outstanding antimicrobial and antibiofilm capabilities.

Funder

Ministry of Education in KSA

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference68 articles.

1. Multidrug resistance: An emerging crisis;Tanwar;Interdiscip. Perspect. Infect. Dis.,2014

2. Targeting multidrug resistance in cancer;Paterson;Nat. Rev. Drug Discov.,2006

3. Adverse drug reactions;Coleman;Clin. Med.,2016

4. Wiffen, P. (2002). Bandolier, NHS Centre for Reviews and Dissemination.

5. Adverse drug reactions;Patton;Anaesthesia,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3